Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID
NCT04403048 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2020-05-27
Summary
Bifurcation lesions (BL) on coronary arteries account for 15-20 % of all performed percutaneous coronary interventions (PCI). Preferred approach for treatment of most bifurcation lesions is the stepwise provisional stent strategy with main branch-only stenting followed by provisional balloon angioplasty with or without stenting of the side branch (SB). Stenting of the side branch is indicated when the angiographic result in SB is clearly suboptimal and when flow remains reduced. Upfront use of two stent techniques may be indicated in very complex lesions with large calcified side branches ( most likely to supply at least 10% of fractional myocardial mass), with a long ostial side branch lesion (\>5mm) or anticipated difficulty in accessing an important side branch after main branch stenting, and true distal LM bifurcations.
From a technical point of view, we propose a "Provisional DCB approach" that differs from the standard provisional approach with obligatory SB predilation and good lesion preparation. In case of an adequate result of predilation, the procedure on the SB ends with the DCB deployment. This is followed by main branch stenting with DES, finished with POT. Final 'kissing' balloon dilation is generally not recommended because there is no advantage from final kissing with the one-stent technique. With this approach, there is no need for re-wiring, re-ballooning, side branching and wire jailing and final kissing. This technique is close to a contemporary approach to bifurcation lesions based on the fundamental philosophy of the European Bifurcation Club (EBC): keep it simple, systematic, and safe, with a limited number of stents that should be well apposed and expanded with limited overlap, with respect of the original bifurcation anatomy.
Conditions
- Stable Angina
- Ischemic Heart Disease
- Coronary Artery Disease
- Unstable Angina
- NSTEMI - Non-ST Segment Elevation MI
Interventions
- PROCEDURE
-
Provisional DCB approach PCI procedure
Intervention is explained in detail in group description
- PROCEDURE
-
Standard provisional approach PCI procedure
Intervention is explained in detail in group description
Sponsors & Collaborators
-
Clinical Hospital Center Rijeka
lead OTHER
Principal Investigators
-
Deiti Prvulovic, MD, PhD · Clinical Hospital Center Rijeka
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-31
- Primary Completion
- 2022-04-30
- Completion
- 2024-04-30
More Related Trials
-
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
NCT04971772 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in Side Branches of de Novo Bifurcation Lesions (DEBSIDE)
NCT01485081 ·Status: COMPLETED ·Phase: NA
-
DCB Compared Stenting in Popliteal Lesions
NCT03739580 ·Status: UNKNOWN ·Phase: NA
-
Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI
NCT04814212 ·Status: RECRUITING ·Phase: NA
-
Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries
NCT03175744 ·Status: SUSPENDED ·Phase: NA
-
Endovascular Treatment of Peripheral Artery Disease (PAD)
NCT03414515 ·Status: COMPLETED
-
Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis
NCT01398033 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effect of Inflation on the Angiographic Result After Balloon Angioplasty in the Femoropopliteal Segment
NCT03428204 ·Status: UNKNOWN ·Phase: NA
-
Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease
NCT02710656 ·Status: COMPLETED ·Phase: NA
-
Drug-Eluting Balloon Registry in Routine Clinical Practice
NCT02038660 ·Status: RECRUITING
-
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
NCT03241459 ·Status: COMPLETED ·Phase: NA
-
Endovascular Treatment of Peripheral Artery Disease
NCT03346577 ·Status: TERMINATED
-
Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions
NCT03129750 ·Status: UNKNOWN
-
Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions
NCT02456402 ·Status: COMPLETED ·Phase: NA
-
Drug Coated Ballon in Critical Limb Ischemia
NCT04737291 ·Status: UNKNOWN ·Phase: NA
-
A Post-Market Study of Drug-Coated Peripheral Balloon Dilatation Catheter in Treating Femoropopliteal Artery Stenosis or Occlusive Lesions.
NCT07187128 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease
NCT01007578 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation
NCT01558505 ·Status: COMPLETED ·Phase: PHASE4
-
The BLIMP Balloon in Coronary Interventions
NCT03947398 ·Status: COMPLETED ·Phase: NA
-
Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.
NCT02939924 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Eluting Balloon for SFA In-stent Restenosis
NCT01616888 ·Status: UNKNOWN ·Phase: NA
-
Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study
NCT03023098 ·Status: COMPLETED ·Phase: NA
-
CVI Drug Coated Balloon First In Human Trial
NCT02110524 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery
NCT01083394 ·Status: UNKNOWN ·Phase: PHASE4
-
Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis
NCT01928498 ·Status: COMPLETED ·Phase: NA